Insight into the physiological and pathological roles of USP44, a potential tumor target (Review)

Oncol Lett. 2022 Nov 1;24(6):455. doi: 10.3892/ol.2022.13575. eCollection 2022 Dec.

Abstract

Ubiquitin-specific peptidase 44 (USP44) is a member of the ubiquitin-specific proteases (USPs) family and its functions in various biological processes have been gradually elucidated in recent years. USP44 targets multiple downstream factors and regulates multiple mechanisms through its deubiquitination activity. Ubiquitination is, in essence, a process in which a single ubiquitin molecule or a multiubiquitin chain binds to a substrate protein to form an isopeptide bond. Deubiquitination is the catalyzing of the isopeptide bonds between ubiquitin and substrate proteins through deubiquitylating enzymes. These two processes serve an important role in the regulation of the expression, conformation, localization and function of substrate proteins by regulating their binding to ubiquitin. Based on existing research, this paper summarized the current state of knowledge about USP44. The physiological roles of USP44 in various cellular events and its pathophysiological roles in different cancer types are evaluated and the therapeutic potential of USP44 for cancer treatment is evaluated.

Keywords: anaphase initiation; deubiquitination; histone H2B K120; tumor-associated protein; ubiquitin-specific peptidase 44.

Publication types

  • Review

Grants and funding

The present study was supported by The National Natural Science Foundation of China (grant no. 81341135), Jinhua Nonprofit Technology Applied Research Projects of Zhejiang China (grant no. 2018-4-016), Jinhua Central Hospital Nonprofit Technology Applied Research Projects of Zhejiang China (grant no, JY2020-5-04) and The Youth Key Project of Shaoxing People's Hospital of Zhejiang China (grant no. 2021YA07).